Page 178 - NobleCon19revC2_Neat
P. 178

Health Care
      Date                  November 21, 2023      Health Care
      52wk High                         $0.34
      52wk Low                          $0.15      Zomedica Corp.                            ZOM       $0.17
                                                   100 Phoenix Drive
                                                   Ann Arbor, MI 48108

                               (USD - in millions)  www.zomedica.com
      Market Cap                       171.2
      Enterprise                        66.7
      Basic Shares Out.               979.95       COMPANY OVERVIEW
      Float                           964.56
      Institutional Holdings           8.53%      Detailed Analysis:Channelchek.com
      Short Interest                   62.89
      Avg. 90-Day Volume                3.36      Zomedica Pharmaceuticals Corp is a veterinary diagnostic and
                                                  pharmaceutical company creating products for companion animals
                                                  (canine, feline and equine) by focusing on the unmet needs of clinical
                                                  veterinarians.
      EPS Data
                     2021     2022       2023
      CQ1             N/A       N/A       N/A
      CQ2             N/A       N/A       N/A

      CQ3             N/A     (0.01)      N/A
      CQ4             N/A       N/A       N/A
      CY            (0.05)    (0.02)      N/A                                            Source: Channelchek/QuoteMedia




      Long-Term EPS Estimate              N/A
      Price/Book (mrq)                   0.27
      ROE (ttm)                         -5.64
      Debt-to-Total Cap. (mrq)           0.67
      Fiscal Year End                 31-Dec
                                                   100 Phoenix DAnn Arbor          MI              48108



      Key Executives
      CEO:      Heaton, Larry
      CFO:      Donato, Peter
      COO:      Blair, Anthony
      IR:       N/A
                                                           Noble Capital Markets, Inc.
      Source: Capital IQ, Noble Financial estimates, company filings
      Noble Senior Analyst                                 561-994-1191   noblecapitalmarkets.com
      Robert LeBoyer                                       MEMBERS: FINRA, SIPC, MSRB
                                                           Following the conference, complete video library of presentations will be
      rleboyer@noblelsp.com                                available at: channelchek.com | nobleconference.com
      (212) 896-4625


      Refer to the back of the book for disclosures
   173   174   175   176   177   178   179   180   181   182   183